Suspension of trading
Valuation Gamida Cell Ltd.
Stocks
GMDA
IL0011552663
Biotechnology & Medical Research
|
Market Closed -
OTC Markets
12:54:51 2024-05-24 EDT
|
5-day change | 1st Jan Change | ||
| 0.0170 USD | +2.41% |
|
-.--% | - |
Company Valuation: Gamida Cell Ltd.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 246.1 | 144.8 | 484.7 | 150.6 | 95.95 | 54.74 |
| Change | - | -41.18% | 234.82% | -68.93% | -36.3% | -42.95% |
| Enterprise Value (EV) 1 | 185.4 | 95.34 | 365.5 | 134.4 | 135.3 | 91.13 |
| Change | - | -48.58% | 283.31% | -63.22% | 0.63% | -32.63% |
| P/E | -0.94x | -2.54x | -5.05x | -1.68x | -1.04x | -0.72x |
| PBR | 10x | 4.14x | 5.01x | 3.47x | -12x | -20.2x |
| PEG | - | 0x | 2.68x | 0.19x | 0.1x | 0x |
| Capitalization / Revenue | - | - | - | - | - | 30,683,808x |
| EV / Revenue | - | - | - | - | - | - |
| EV / EBITDA | -5.56x | -1.99x | -5.9x | -1.55x | -1.81x | -1.29x |
| EV / EBIT | -5.51x | -1.98x | -5.87x | -1.54x | -1.8x | -1.25x |
| EV / FCF | -11.8x | -4.03x | -9.63x | -2.25x | -2.88x | -1.75x |
| FCF Yield | -8.45% | -24.8% | -10.4% | -44.4% | -34.7% | -57.1% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -10.53 | -1.695 | -1.663 | -1.516 | -1.244 | -0.5724 |
| Distribution rate | - | - | - | - | - | - |
| Net sales | - | - | - | - | - | 1.784 |
| EBITDA 1 | -33.38 | -47.92 | -61.94 | -86.74 | -74.55 | -70.62 |
| EBIT 1 | -33.64 | -48.24 | -62.3 | -87.17 | -74.99 | -72.64 |
| Net income 1 | -52.93 | -34.35 | -72.7 | -89.79 | -79.38 | -63 |
| Net Debt 1 | -60.69 | -49.43 | -119.3 | -16.21 | 39.31 | 36.39 |
| Reference price 2 | 9.9400 | 4.3000 | 8.3900 | 2.5400 | 1.2900 | 0.4127 |
| Nbr of stocks (in thousands) | 24,761 | 33,667 | 57,774 | 59,299 | 74,381 | 132,639 |
| Announcement Date | 2/25/19 | 2/26/20 | 3/9/21 | 3/24/22 | 3/31/23 | 3/27/24 |
1USD in Million2USD
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 2.62M | |
| 21.73x | 7.71x | 15.48x | 1.37% | 74.16B | |
| 29.82x | 8.57x | 26.7x | 0.04% | 57.39B | |
| 32.98x | 5.93x | 17.77x | 0.98% | 47.64B | |
| -21.31x | 230.81x | -22.97x | -.--% | 44.29B | |
| 33.26x | 3.23x | 13.97x | -.--% | 42.5B | |
| 46.77x | 5.41x | 29.66x | -.--% | 40.71B | |
| 27.63x | 7.93x | 20.48x | 0.41% | 30.97B | |
| 32.99x | 7.05x | 18.3x | -.--% | 28.53B | |
| -15.1x | 5.68x | -7.14x | -.--% | 24.34B | |
| Average | 20.98x | 31.37x | 12.47x | 0.31% | 39.05B | |
| Weighted average by Cap. | 22.27x | 32.04x | 13.55x | 0.42% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- GMDA Stock
- Valuation Gamida Cell Ltd.
Select your edition
All financial news and data tailored to specific country editions
